As of 2004, the National Cancer Institute is sponsoring 10 clinical trials of treatments for ocular melanoma in adults and 5 trials for treatments of retinoblastoma in children. These trials allow researchers to investigate new types of.
Breast Cancer clinical trials are used to test new medicines, procedures, and surgeries to better aid in the treatment and finding a cure for the cancer.
The Reliv company does not say it does. If it did cure something, the company would advertise that fact. Also, no clinical trials were ever conducted to see if it cures anything.
Since Hepatitis B reactive is an acute reaction, it can be treated. Hepatitis B reactive can be treated with antibiotics and other clinical trials that are being tested.
The Reliv company does not say it does. If it did cure something, the company would advertise that fact. Also, no clinical trials were ever conducted to see if it cures anything.
The Reliv company does not say it does. If it did cure something, the company would advertise that fact. Also, no clinical trials were ever conducted to see if it cures anything.
The death cure comes after the scorch trials
The HSG, or Huntington Study Group, is a group of people who participate in different clinical trials. The sole purpose of the Huntington Study Group is to find a cure for Huntington's Disease, which is a gene.
Crohn's disease has no cure. Research is ongoing, new medications and treatments are being investigated with clinical trials in several countries however no cure is available. Right now the best we can hope for is control and relief of symptoms.
No. Reliv claims to be a nutritional supplement.
Techniquely, yes! Fidaxomicin is an antibiotic that belongs to the class of the macrocyclics and is indicated for the treatment of CDI. In clinical trials, fidaxomicin, when compared to vancomycin, was non-inferior for the clinical cure of patients with CDI and superior for the reduction of recurrence rates, with a greater sustained response after 30 days. Of the patients included in the clinical trials, additional subgroup analyses were performed in patient subgroups with a higher risk of recurrence than the overall CDI population. I found the answer from the website of BOC Sciences.
Yes, scientists have managed to grow hair on mice, which proves promising for clinical trials and applications to human beings. http://www.huffingtonpost.com/2011/02/17/scientists-may-have-found_n_824551.html
The question is a bit unclear. However, there are a number of clinical trials taking place in the United States and elsewhere that are working on finding either a vaccine against the HIV virus or a cure for those who already have it.